↓ Skip to main content

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

Overview of attention for article published in Annals of Internal Medicine, February 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

policy
1 policy source
guideline
5 clinical guideline sources

Readers on

mendeley
180 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United Kingdom 2 1%
Portugal 1 <1%
Italy 1 <1%
Brazil 1 <1%
Unknown 175 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 33 18%
Student > Master 22 12%
Other 14 8%
Student > Bachelor 14 8%
Student > Ph. D. Student 14 8%
Other 41 23%
Unknown 42 23%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 71 39%
Nursing and Health Professions 14 8%
Pharmacology, Toxicology and Pharmaceutical Science 14 8%
Agricultural and Biological Sciences 8 4%
Biochemistry, Genetics and Molecular Biology 5 3%
Other 18 10%
Unknown 50 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2016.
All research outputs
#2,552,676
of 34,411,289 outputs
Outputs from Annals of Internal Medicine
#5,470
of 16,869 outputs
Outputs of similar age
#13,402
of 261,154 outputs
Outputs of similar age from Annals of Internal Medicine
#25
of 101 outputs
Altmetric has tracked 34,411,289 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,869 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 57.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 261,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.